Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT

被引:21
|
作者
Kunz, Wolfgang G. [1 ]
Eschbach, Ralf S. [1 ]
Stahl, Robert [1 ]
Kazmierczak, Philipp M. [1 ]
Bartenstein, Peter [2 ]
Rominger, Axel [2 ]
Auernhammer, Christoph J. [3 ,4 ,5 ]
Spitzweg, Christine [3 ,4 ,5 ]
Ricke, Jens [1 ]
Cyran, Clemens C. [1 ,4 ,5 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[3] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Internal Med 4, Munich, Germany
[4] Ludwig Maximilians Univ Munchen, Univ Hosp, Comprehens Canc Ctr CCC LMU, Munich, Germany
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Interdisciplinary Ctr Neuroendocrine Tumors Gastr, Munich, Germany
来源
CANCER IMAGING | 2018年 / 18卷
关键词
Myocardium; Neuroendocrine tumors; Positron-emission tomography; Multidetector computed tomography; CARCINOID HEART-DISEASE; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; GUIDELINES; MANAGEMENT;
D O I
10.1186/s40644-018-0168-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Focal 68Ga-DOTATATE PET lesions within the myocardium of neuroendocrine tumor (NET) patients are observed in clinical practice. We determined the frequency and characteristics of lesions that are consistent with cardiac metastasis and assessed the lesion detection rate of conventional imaging. Methods: 629 patients who underwent 68Ga-DOTATATE PET-CT at a supraregional comprehensive cancer center on NET were included from a consecutive registry. Inclusion criteria were: (1) focal 68Ga-DOTATATE tracer uptake within the myocardium in more than two sequential PET exams, and (2) contrast-enhanced CT. To determine the diagnostic accuracy of conventional CT imaging, a case-control cohort with a ratio of 1:3 was used. PET and CT were independently analyzed by two blinded readers. Cohen's K was assessed for interreader agreement Descriptive statistics were applied for frequencies and characteristics and group comparisons were analyzed using the Fisher's exact test. Results: The prevalence of myocardial metastases related to the registry was 2.4% (15 of 629 NET patients fulfilling the inclusion criteria), for a total of 21 myocardial 68Ga-DOTATATE foci detected. Myocardial lesions were most frequently located in the left ventricle (43%) and the septum (43%). No patient demonstrated a pericardial effusion. Patients with myocardial metastases did not differ in demographics, tumor grading, disease stage or circulating tumor markers compared to the overall registry (all p > 0.05). Higher Ki67-Indices were observed (p = 0.049) for patients with myocardial metastases. Interreader agreement for PET assessment was excellent (Cohen's K = 1.0). CT reading showed a sensitivity of 19% (95% confidence interval: 6-43%) at a specificity of 100% (95% confidence interval: 90-100%). Conclusions: 68Ga-DOTATATE PET enables detection of myocardial metastatic lesions in NET patients. In contrast, standard morphologic CT imaging provides very limited sensitivity.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
    Wolfgang G. Kunz
    Ralf S. Eschbach
    Robert Stahl
    Philipp M. Kazmierczak
    Peter Bartenstein
    Axel Rominger
    Christoph J. Auernhammer
    Christine Spitzweg
    Jens Ricke
    Clemens C. Cyran
    Cancer Imaging, 18
  • [2] Neuroendocrine Tumor Recurrence: Diagnosis with 68Ga-DOTATATE PET/CT
    Haug, Alexander R.
    Cindea-Drimus, Ramona
    Auernhammer, Christoph J.
    Reincke, Martin
    Beuschlein, Felix
    Waengler, Bjoern
    Uebleis, Christopher
    Schmidt, Gerwin P.
    Spitzweg, Christine
    Bartenstein, Peter
    Hacker, Marcus
    RADIOLOGY, 2014, 270 (02) : 517 - 525
  • [3] 68Ga-DOTATATE PET/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin
    Alonso, Omar
    Rodriguez-Taroco, Monica
    Savio, Eduardo
    Bentancourt, Cecilia
    Gambini, Juan P.
    Engler, Henry
    ANNALS OF NUCLEAR MEDICINE, 2014, 28 (07) : 638 - 645
  • [4] The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors
    Haug, Alexander R.
    Cindea-Drimus, Ramona
    Auernhammer, Christoph J.
    Reincke, Martin
    Waengler, Bjoern
    Uebleis, Christopher
    Schmidt, Gerwin P.
    Goeke, Burkhard
    Bartenstein, Peter
    Hacker, Marcus
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (11) : 1686 - 1692
  • [5] Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT
    Ingenerf, Maria
    Grawe, Freba
    Winkelmann, Michael
    Karim, Homeira
    Ruebenthaler, Johannes
    Fabritius, Matthias Philipp
    Ricke, Jens
    Seidensticker, Ricarda
    Auernhammer, Christoph Josef
    Zacherl, Mathias Johannes
    Seidensticker, Max
    Schmid-Tannwald, Christine
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2024, 105 (01) : 15 - 25
  • [6] 68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor
    Komek, Halil
    Gundogan, Cihan
    Can, Canan
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : E290 - E292
  • [7] False Positive of 68Ga-DOTATATE PET-CT in a Paraganglioma
    Zampetti, Benedetta
    Attanasio, Roberto
    Boniardi, Marco
    Cozzi, Renato
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (07) : 1352 - 1355
  • [8] Management Impact of 68Ga-DOTATATE PET/CT in Neuroendocrine Tumors
    Anderson, Redmond-Craig
    Velez, Erik M.
    Desai, Bhushan
    Jadvar, Hossein
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 55 (01) : 31 - 37
  • [9] Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer
    Tuncel, Murat
    Kilickap, Saadettin
    Suslu, Nilda
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (09) : 663 - 674
  • [10] 68Ga-DOTATATE PET-CT imaging in carotid body paragangliomas
    Simsek, Duygu Has
    Sanli, Yasemin
    Kuyumcu, Serkan
    Basaran, Bora
    Mudun, Ayse
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (04) : 297 - 301